Replacing Western blotting with Lumit™ Cellular Systems for Drug Discovery.
Dr Tracey Martin is a Senior Lecturer in Cell and Tumour Biology at the Cardiff China Medical Research Collaborative at Cardiff University, an award-winning medical and cancer research group working in collaboration with some of China’s leading cancer organisations. The collaboration undertakes cancer research to benefit the diagnosis, prevention and treatment of cancer.
In this short video Dr Martin talks about her research in the field of cancer metastasis, with a focus on how cancer cells are able to cross the blood brain barrier to form secondary tumours in the brain. Her current project involves screening 150 novel compounds to find modulators of the motility protein N-WASP. Labour intensive Western blots were replaced with Lumit™ Cellular Systems, increasing throughput and improving both the reliability and consistency of data generated.
Lumit™ Immunoassay Cellular System is a no-wash bioluminescent immunoassay that measures target analytes directly in cell lysates. The assay can be adapted to detect any phosphoprotein, total protein or small molecule of interest, provided that appropriate primary antibodies (supplied by the user) are available.
Lumit™ Technology: Reliable, Automation-Friendly Immunodetection
Lumit™ Immunoassay Cellular Systems
Download the PDF of the case study here >
View and Download the Transcript >